US-based Eli Lilly's Kisunla drug and Japanese company Eisai's Leqembi (below), two breakthrough drugs for the diagnosis and ...

Since traditional Chinese medicine treats not only the secondary manifestations (biao) but also the primary causes (ben) of ...